GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region

Agence France-Presse (AFP)State / PublicCenter11 days ago

GENESIS Pharma has expanded its strategic commercial partnership with Alnylam Pharmaceuticals to include the Nordic region, focusing on RNAi therapeutics.

Bias read (Center): The article reports on a business expansion between two pharmaceutical companies without any political commentary, framing, or biased language. The subject matter is purely commercial and does not involve political controversy.